Genesis Healthcare

About:

Genesis Healthcare is a genetic testing company that provides research, development, and complete end-to-end genetic services.

Website: http://genesis-healthcare.jp/en/

Twitter/X: GL_GeneLife

Top Investors: Founders Fund, Rakuten, Mitsui & Co, Omron Healthcare

Description:

Genesis Healthcare is a privately-owned Japanese genetic testing and research company headquartered in Japan since 2004. With launching new Asian headquarters in Singapore and its branch in Taiwan early 2018, we currently offer services across Southeast Asia. Possessing the largest genetic database in Japan and Asia comprising over 988,000 people and 1,500 diseases, Genesis Healthcare provides research and clinically validated genetic testing services using the most advanced PCR, Microarray and NGS technology. Genesis Healthcare is also Japan’s top market leader in the consumer genetics segment with its brand “GeneLife,” and promotes preventive healthcare through genetic testing. To purchase our genetic testing kits, please visit https://www.genelife.asia/product As the pioneer in genetic research and testing in Japan, Genesis Healthcare works closely with various government agencies in formulating genetic testing guidelines to secure accuracy and protect individuals’ genetic information.

Total Funding Amount:

$33.1M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Tokyo, Tokyo, Japan

Founded Date:

2004-03-01

Founders:

David Baran, Iri Sato Baran, Kayama Tetsu, Mickey Mikitani

Number of Employees:

101-250

Last Funding Date:

2018-02-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai